2022 Help me understand this report
Special Issue “Antibody Engineering for Cancer Immunotherapy”
Abstract: Since the approval of Rituximab in the late 1990s, the first chimeric monoclonal antibody for the treatment of non-Hodgkin lymphoma, antibody engineering for cancer immunotherapy has become a rapidly growing field, with almost 50 antibody therapeutics approved in the USA and EU and hundreds undergoing testing in clinical trials [...]
Search citation statements
Paper Sections
Select...
Citation Types
0
0
0
Year Published
2023
2023
Publication Types
Select...
1
Relationship
0
1
Authors
Journals
Cited by 1 publication
References 10 publications
(10 reference statements)
0
0
0
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
